Apyx Medical
APYX
67 hedge funds and large institutions have $76.8M invested in Apyx Medical in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 7 closing their positions.
1,279% more call options, than puts
Call options by funds: $331K | Put options by funds: $24K
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
44% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 16
15% more capital invested
Capital invested by funds: $66.9M → $76.8M (+$9.87M)
14% more funds holding
Funds holding: 59 → 67 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.25% less ownership
Funds ownership: 50% → 49.75% (-0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$3.37M |
| 2 |
SEI Investments
Oaks,
Pennsylvania
|
+$1.67M |
| 3 |
LCM
Legato Capital Management
San Francisco,
California
|
+$1.05M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$859K |
| 5 |
Millennium Management
New York
|
+$633K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.99M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$1.58M |
| 3 |
6CM
683 Capital Management
New York
|
-$391K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$305K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$172K |
APYX Hedge Fund Activity: Q1 2026 in Review
67 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2026, worth a combined $76.8M — up 15% from $66.9M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new APYX positions and 7 closed out — a net gain of 9 holders — while 23 added to existing stakes and 16 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $3.37M. The largest seller was Nantahala Capital Management, cutting an estimated $1.99M.
- 67 institutional investors held Apyx Medical (APYX) as of Q1 2026, up from 59 in Q4 2025.
- Funds reported $76.8M of Apyx Medical stock for Q1 2026, up 15% quarter-over-quarter.
- 16 funds opened new Apyx Medical positions in Q1 2026 and 7 closed out, a net change of +9 holders.
- The largest Apyx Medical buyer in Q1 2026 was Essex Investment Management, an estimated $3.37M added.
- The largest Apyx Medical seller in Q1 2026 was Nantahala Capital Management, an estimated $1.99M sold.
Based on aggregated 13F filings for Q1 2026.